Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

80.1K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
80.1K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.5K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

1.3K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.3K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

69.6K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
69.6K
DNA Bacteriophages01:26

DNA Bacteriophages

1.4K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.4K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

84
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
84

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular insights into the protective role of nano-naringin in mancozeb-induced testicular damage and infertility.

Biological research·2026
Same author

Modular plug-and-play engineering of Klebsiella phages with dual receptor-binding proteins for efficient host range design.

Journal of biological engineering·2026
Same author

PhaLP 2.0: extending the community-oriented phage lysin database with a SUBLYME pipeline for metagenomic discovery.

Database : the journal of biological databases and curation·2026
Same author

Comparative Evaluation of Polymeric Nanocarriers for DNA Vaccine Delivery Against <i>Avian Orthoavulavirus 1</i> in Chickens.

Viruses·2026
Same author

Disruptive innovation in antibiotic development: a vision for lysins.

Expert review of anti-infective therapy·2026
Same author

DepoCatalog: mapping diversity of 129 recombinantly produced Klebsiella phage depolymerases.

Nature communications·2026

Related Experiment Video

Updated: Apr 2, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.6K

Engineered phage-derived lysins effectively kill mycobacterial pathogens.

Adel Abouhmad1, Jana Kassaliete2, Camilla Davids2

  • 1Division of Biotechnology, Department of Chemistry, Kemicentrum, Lund University, Box 124, Lund SE-221 00, Sweden; Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.

Trends in Biotechnology
|March 31, 2026
PubMed
Summary

Researchers developed a novel mycolysin platform using phage enzymes to overcome mycobacterial cell wall barriers. This approach shows promise for developing next-generation antimycobacterial therapies against resistant strains.

Keywords:
Lysin ALysin BVersaTile technologyantimicrobial resistancemycobacterial pathogensmycolysin

More Related Videos

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
09:01

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi

Published on: September 28, 2022

2.9K
Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.6K

Related Experiment Videos

Last Updated: Apr 2, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.6K
Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
09:01

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi

Published on: September 28, 2022

2.9K
Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.6K

Area of Science:

  • Biotechnology
  • Microbiology
  • Drug Discovery

Background:

  • Antimicrobial resistance in mycobacteria is a significant global health threat.
  • The complex mycobacterial cell wall impedes drug penetration, requiring lengthy treatments.
  • Mycobacteriophages possess enzymes capable of degrading the mycobacterial cell wall.

Purpose of the Study:

  • To engineer a modular mycolysin platform combining phage enzymes with cell-penetrating moieties.
  • To screen and identify potent mycolysin candidates against pathogenic mycobacteria.
  • To evaluate the efficacy and safety of lead mycolysin candidates.

Main Methods:

  • Utilized VersaTile shuffling technology to create chimeric mycolysin libraries.
  • Screened libraries against Mycobacterium smegmatis and Mycobacterium bovis Bacillus Calmette-Guérin (BCG).
  • Assessed minimum inhibitory concentrations (MICs), intracellular efficacy, serum stability, cytotoxicity, and in vivo efficacy.

Main Results:

  • Identified potent mycolysin candidates with MICs as low as 1.28 μg/ml against M. bovis BCG.
  • Demonstrated intracellular efficacy, serum stability, and noncytotoxicity of lead compounds.
  • Showcased in vivo proof-of-concept efficacy in rat models and synergy with rifampicin.

Conclusions:

  • The developed mycolysin platform effectively targets mycobacterial cell walls.
  • These phage-derived enzymes represent a promising strategy for next-generation antimycobacterial therapies.
  • The modular platform offers a versatile framework for engineering novel antimicrobials.